215 related articles for article (PubMed ID: 37864589)
1. Exploring the logic and conducting a comprehensive evaluation of AdipoRon-based adiponectin replacement therapy against hormone-related cancers-a systematic review.
Laurindo LF; Sosin AF; Lamas CB; de Alvares Goulart R; Dos Santos Haber JF; Detregiachi CRP; Barbalho SM
Naunyn Schmiedebergs Arch Pharmacol; 2024 Apr; 397(4):2067-2082. PubMed ID: 37864589
[TBL] [Abstract][Full Text] [Related]
2. AdipoRon and ADP355, adiponectin receptor agonists, in Metabolic-associated Fatty Liver Disease (MAFLD) and Nonalcoholic Steatohepatitis (NASH): A systematic review.
Barbalho SM; Méndez-Sánchez N; Fornari Laurindo L
Biochem Pharmacol; 2023 Dec; 218():115871. PubMed ID: 37866803
[TBL] [Abstract][Full Text] [Related]
3. AdipoRon, an adiponectin receptor agonist, attenuates PDGF-induced VSMC proliferation through inhibition of mTOR signaling independent of AMPK: Implications toward suppression of neointimal hyperplasia.
Fairaq A; Shawky NM; Osman I; Pichavaram P; Segar L
Pharmacol Res; 2017 May; 119():289-302. PubMed ID: 28237515
[TBL] [Abstract][Full Text] [Related]
4. AdipoRon improves cognitive dysfunction of Alzheimer's disease and rescues impaired neural stem cell proliferation through AdipoR1/AMPK pathway.
Liu B; Liu J; Wang JG; Liu CL; Yan HJ
Exp Neurol; 2020 May; 327():113249. PubMed ID: 32070713
[TBL] [Abstract][Full Text] [Related]
5. The Adiponectin Receptor Agonist AdipoRon Ameliorates Diabetic Nephropathy in a Model of Type 2 Diabetes.
Kim Y; Lim JH; Kim MY; Kim EN; Yoon HE; Shin SJ; Choi BS; Kim YS; Chang YS; Park CW
J Am Soc Nephrol; 2018 Apr; 29(4):1108-1127. PubMed ID: 29330340
[TBL] [Abstract][Full Text] [Related]
6. AdipoRon, the first orally active adiponectin receptor activator, attenuates postischemic myocardial apoptosis through both AMPK-mediated and AMPK-independent signalings.
Zhang Y; Zhao J; Li R; Lau WB; Yuan YX; Liang B; Li R; Gao EH; Koch WJ; Ma XL; Wang YJ
Am J Physiol Endocrinol Metab; 2015 Aug; 309(3):E275-82. PubMed ID: 26037251
[TBL] [Abstract][Full Text] [Related]
7. Adiponectin receptor agonist AdipoRon induces apoptotic cell death and suppresses proliferation in human ovarian cancer cells.
Ramzan AA; Bitler BG; Hicks D; Barner K; Qamar L; Behbakht K; Powell T; Jansson T; Wilson H
Mol Cell Biochem; 2019 Nov; 461(1-2):37-46. PubMed ID: 31292831
[TBL] [Abstract][Full Text] [Related]
8. AdipoRon: a possible drug for colorectal cancer prevention?
Malih S; Najafi R
Tumour Biol; 2015 Sep; 36(9):6673-5. PubMed ID: 26282004
[TBL] [Abstract][Full Text] [Related]
9. AdipoRon Protects Against Secondary Brain Injury After Intracerebral Hemorrhage via Alleviating Mitochondrial Dysfunction: Possible Involvement of AdipoR1-AMPK-PGC1α Pathway.
Yu J; Zheng J; Lu J; Sun Z; Wang Z; Zhang J
Neurochem Res; 2019 Jul; 44(7):1678-1689. PubMed ID: 30982205
[TBL] [Abstract][Full Text] [Related]
10. AdipoRon, an adiponectin receptor agonist, protects contrast-induced nephropathy by suppressing oxidative stress and inflammation via activation of the AMPK pathway.
Gu D; Shi Y; Gong Z; Xia T; Ren H; He D; Yang J; Han Y; Zeng C
Clin Exp Nephrol; 2020 Nov; 24(11):989-998. PubMed ID: 32734507
[TBL] [Abstract][Full Text] [Related]
11. Activation of adiponectin receptors has negative impact on muscle mass in C2C12 myotubes and fast-type mouse skeletal muscle.
Ito R; Higa M; Goto A; Aoshima M; Ikuta A; Ohashi K; Yokoyama S; Ohno Y; Egawa T; Miyata H; Goto K
PLoS One; 2018; 13(10):e0205645. PubMed ID: 30308063
[TBL] [Abstract][Full Text] [Related]
12. The adiponectin agonist, AdipoRon, inhibits steroidogenesis and cell proliferation in human luteinized granulosa cells.
Grandhaye J; Hmadeh S; Plotton I; Levasseur F; Estienne A; LeGuevel R; Levern Y; Ramé C; Jeanpierre E; Guerif F; Dupont J; Froment P
Mol Cell Endocrinol; 2021 Jan; 520():111080. PubMed ID: 33189865
[TBL] [Abstract][Full Text] [Related]
13. Restoring diabetes-induced autophagic flux arrest in ischemic/reperfused heart by ADIPOR (adiponectin receptor) activation involves both AMPK-dependent and AMPK-independent signaling.
Wang Y; Liang B; Lau WB; Du Y; Guo R; Yan Z; Gan L; Yan W; Zhao J; Gao E; Koch W; Ma XL
Autophagy; 2017; 13(11):1855-1869. PubMed ID: 28825851
[TBL] [Abstract][Full Text] [Related]
14. Adiponectin receptor agonist AdipoRon attenuates calcification of osteoarthritis chondrocytes by promoting autophagy.
Duan ZX; Tu C; Liu Q; Li SQ; Li YH; Xie P; Li ZH
J Cell Biochem; 2020 Jun; 121(5-6):3333-3344. PubMed ID: 31898335
[TBL] [Abstract][Full Text] [Related]
15. Adiponectin receptor agonist AdipoRon modulates human and mouse platelet function.
Zhou XH; Cheng ZP; Lu M; Lin WY; Luo LL; Ming ZY; Hu Y
Acta Pharmacol Sin; 2023 Feb; 44(2):356-366. PubMed ID: 35918410
[TBL] [Abstract][Full Text] [Related]
16. Discovery of AdipoRon analogues as novel AMPK activators without inhibiting mitochondrial complex I.
Sun G; You Y; Li H; Cheng Y; Qian M; Zhou X; Yuan H; Xu QL; Dai L; Wang P; Cheng K; Wen X; Chen C
Eur J Med Chem; 2020 Aug; 200():112466. PubMed ID: 32512485
[TBL] [Abstract][Full Text] [Related]
17. Adiponectin receptor agonist AdipoRon suppresses adipogenesis in C3H10T1/2 cells through the adenosine monophosphate‑activated protein kinase signaling pathway.
Wang SJ; Lu WY; Liu KY
Mol Med Rep; 2017 Nov; 16(5):7163-7169. PubMed ID: 28901521
[TBL] [Abstract][Full Text] [Related]
18. Synthetic adiponectin-receptor agonist, AdipoRon, induces glycolytic dependence in pancreatic cancer cells.
Manley SJ; Olou AA; Jack JL; Ruckert MT; Walsh RM; Eades AE; Bye BA; Ambrose J; Messaggio F; Anant S; VanSaun MN
Cell Death Dis; 2022 Feb; 13(2):114. PubMed ID: 35121743
[TBL] [Abstract][Full Text] [Related]
19. AdipoRon Attenuates Neuroinflammation After Intracerebral Hemorrhage Through AdipoR1-AMPK Pathway.
Zheng J; Sun Z; Liang F; Xu W; Lu J; Shi L; Shao A; Yu J; Zhang J
Neuroscience; 2019 Aug; 412():116-130. PubMed ID: 31176703
[TBL] [Abstract][Full Text] [Related]
20. AdipoRon induces AMPK activation and ameliorates Alzheimer's like pathologies and associated cognitive impairment in APP/PS1 mice.
Khandelwal M; Manglani K; Upadhyay P; Azad M; Gupta S
Neurobiol Dis; 2022 Nov; 174():105876. PubMed ID: 36162737
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
